Holdings
Bain Capital Life Sciences Investors, LLC
As of Jun 30, 2026, Bain Capital Life Sciences Investors, LLC reported 17 positions worth US$1.36B. Largest: Kailera Therapeutics, Inc., Heartflow, Inc. and Savara, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Kailera Therapeutics, Inc. | 22.6M | US$498M | new | Jun 30, 2026 |
| Heartflow, Inc. | 8.45M | US$248M | −2M | Jun 30, 2026 |
| Savara, Inc. | 17.6M | US$108M | no change | Jun 30, 2026 |
| Solid Biosciences Inc. | 9.81M | US$98M | no change | Jun 30, 2026 |
| Olema Pharmaceuticals, Inc. | 7.09M | US$88.6M | −388K | Jun 30, 2026 |
| Hemab Therapeutics Holdings, Inc. | 1.65M | US$60.6M | new | Jun 30, 2026 |
| Cabaletta Bio, Inc. | 17.2M | US$53.6M | +7.56M | Jun 30, 2026 |
| X4 Pharmaceuticals, Inc. | 7.97M | US$37.2M | no change | Jun 30, 2026 |
| Dianthus Therapeutics, Inc. | 362K | US$35.3M | no change | Jun 30, 2026 |
| C4 Therapeutics, Inc. | 7.17M | US$33.5M | no change | Jun 30, 2026 |